EST
DGX icon

EA Series Trust’s Quest Diagnostics DGX Stock Holding History

EA Series Trust’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$1.37M Buy
+9,782
New +$1.35M 0.05% 523

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

EA Series Trust's DGX Position: Q2 2023 in Review

EA Series Trust opened a new position in Quest Diagnostics (DGX) in Q2 2023: 9,782 shares worth $1.37M. The stake represents 0.05% of the portfolio and ranks #523 among its holdings.

819 funds tracked by Wall St. Rank hold DGX as of Q2 2023.

  • EA Series Trust held 9,782 shares of Quest Diagnostics worth $1.37M as of Q2 2023.
  • Quest Diagnostics was a new EA Series Trust position in Q2 2023.
  • Quest Diagnostics made up 0.05% of EA Series Trust's portfolio in Q2 2023, its #523 holding.
  • 819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.